Folger Nolan Fleming Douglas Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.4M Sell
127,783
-618
-0.5% -$72.3K 1.34% 20
2026
Q1
$15.4M Buy
128,401
+59,377
+86% +$6.86M 1.38% 23
2025
Q4
$7.27M Sell
69,024
-289
-0.4% -$27.1K 0.75% 38
2025
Q3
$5.82M Buy
69,313
+410
+0.6% +$33.8K 0.61% 43
2025
Q2
$5.45M Sell
68,903
-477
-0.7% -$37.9K 0.61% 45
2025
Q1
$6.23M Sell
69,380
-31
-0% -$2.89K 0.7% 40
2024
Q4
$6.91M Sell
69,411
-5,854
-8% -$604K 0.72% 39
2024
Q3
$8.55M Sell
75,265
-2,431
-3% -$289K 0.84% 34
2024
Q2
$9.62M Sell
77,696
-872
-1% -$112K 0.98% 28
2024
Q1
$10.4M Sell
78,568
-549
-0.7% -$67.7K 1.06% 26
2023
Q4
$8.63M Sell
79,117
-682
-0.9% -$70.8K 0.94% 29
2023
Q3
$8.21M Sell
79,799
-11,228
-12% -$1.21M 0.96% 29
2023
Q2
$10.5M Buy
91,027
+915
+1% +$104K 1.14% 26
2023
Q1
$9.59M Sell
90,112
-2,618
-3% -$283K 1.12% 26
2022
Q4
$10.5M Buy
92,730
+6,392
+7% +$653K 1.25% 23
2022
Q3
$7.43M Buy
86,338
+822
+1% +$73.4K 1.01% 29
2022
Q2
$7.8M Sell
85,516
-1,750
-2% -$155K 1.02% 30
2022
Q1
$7.16M Buy
87,266
+129
+0.1% +$10.2K 0.8% 37
2021
Q4
$6.68M Sell
87,137
-60
-0.1% -$4.78K 0.73% 38
2021
Q3
$6.55M Buy
87,197
+6,735
+8% +$512K 0.79% 37
2021
Q2
$6.26M Sell
80,462
-1,855
-2% -$138K 0.72% 41
2021
Q1
$6.05M Buy
82,317
+1,897
+2% +$140K 0.74% 40
2020
Q4
$6.28M Sell
80,420
-1,172
-1% -$89.6K 0.83% 36
2020
Q3
$6.46M Buy
81,592
+1,624
+2% +$127K 0.97% 31
2020
Q2
$5.9M Buy
79,968
+1,608
+2% +$121K 0.96% 31
2020
Q1
$5.75M Buy
78,360
+29
+0% +$2.28K 1.15% 26
2019
Q4
$6.8M Sell
78,331
-456
-0.6% -$37.5K 0.99% 32
2019
Q3
$6.33M Buy
78,787
+1,519
+2% +$122K 0.98% 31
2019
Q2
$6.18M Buy
77,268
+907
+1% +$69.4K 0.92% 31
2019
Q1
$6.06M Buy
76,361
+204
+0.3% +$15.3K 0.91% 30
2018
Q4
$5.55M Buy
76,157
+702
+0.9% +$49.6K 0.91% 30
2018
Q3
$5.11M Buy
75,455
+2,961
+4% +$189K 0.72% 37
2018
Q2
$4.2M Sell
72,494
-435
-0.6% -$24.5K 0.61% 39
2018
Q1
$3.79M Sell
72,929
-1,541
-2% -$83.2K 0.56% 41
2017
Q4
$4M Sell
74,470
-1,226
-2% -$68K 0.56% 40
2017
Q3
$4.63M Sell
75,696
-1,996
-3% -$121K 0.67% 34
2017
Q2
$4.75M Sell
77,692
-1,797
-2% -$109K 0.73% 30
2017
Q1
$4.82M Sell
79,489
-222
-0.3% -$13.5K 0.72% 31
2016
Q4
$4.46M Hold
79,711
0.74% 34
2016
Q3
$4.46M Sell
79,711
-78
-0.1% -$4.56K 0.74% 34
2016
Q2
$4.39M Sell
79,789
-1,855
-2% -$98.7K 0.75% 33
2016
Q1
$4.12M Buy
81,644
+1,776
+2% +$87K 0.74% 35
2015
Q4
$4.03M Sell
79,868
-855
-1% -$43.1K 0.72% 33
2015
Q3
$3.8M Buy
80,723
+4,057
+5% +$216K 0.78% 34
2015
Q2
$4.16M Buy
76,666
+476
+0.6% +$26.7K 0.77% 27
2015
Q1
$4.18M Buy
76,190
+1,410
+2% +$79.8K 0.73% 31
2014
Q4
$4.05M Buy
74,780
+2,637
+4% +$147K 0.7% 34
2014
Q3
$4.08M Buy
72,143
+2,921
+4% +$164K 0.74% 29
2014
Q2
$3.82M Buy
69,222
+3,688
+6% +$201K 0.7% 32
2014
Q1
$3.55M Sell
65,534
-1,528
-2% -$79.1K 0.73% 31
2013
Q4
$3.2M Buy
67,062
+2,344
+4% +$107K 0.56% 37
2013
Q3
$2.94M Buy
64,718
+6,036
+10% +$276K 0.57% 36
2013
Q2
$2.6M Buy
+58,682
New +$2.62M 0.54% 39

Other funds holding MRK

Folger Nolan Fleming Douglas Capital Management's MRK Position: Q2 2026 in Review

Folger Nolan Fleming Douglas Capital Management reduced its Merck (MRK) stake by 0.48% in Q2 2026, selling an estimated $72.3K and leaving 127,783 shares worth $16.4M. The position accounts for 1.34% of the portfolio, ranked #20.

Folger Nolan Fleming Douglas Capital Management first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. 1,320 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Folger Nolan Fleming Douglas Capital Management held 127,783 shares of Merck worth $16.4M as of Q2 2026.
  • Folger Nolan Fleming Douglas Capital Management sold 618 Merck shares in Q2 2026, an estimated $72.3K.
  • Merck made up 1.34% of Folger Nolan Fleming Douglas Capital Management's portfolio in Q2 2026, its #20 holding.
  • Folger Nolan Fleming Douglas Capital Management first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • 1,320 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Folger Nolan Fleming Douglas Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.